Navigation Links
Novadaq to present at Cowen Healthcare Conference
Date:3/11/2008

ence which allows surgeons to differentiate between healthy and cancerous tissue in the lung during thoracic surgery. Novadaq is also the exclusive United States distributor of PLC Medical's CO2 HEART LASER(TM) System for TMR (Trans-Myocardial Revascularization). For more information, please visit the company's website at http://www.novadaq.com.

Forward looking Statements

Certain statements included in this press release may be considered forward-looking. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on Novadaq's current beliefs as well as assumptions made by and information currently available to Novadaq and relate to, among other things, anticipated financial performance, business prospects, strategies, regulatory developments, market acceptance and future commitments. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by Novadaq in its public securities filings; actual events may differ materially from current expectations. Novadaq disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Novadaq Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. NOVADAQs SPY System to be Featured During Live Broadcast of Robotic Surgery
2. Novadaq Data Presented at 2008 Society of Thoracic Surgeons Meeting
3. Novadaqs SPY System receives clearance for use in organ transplant surgery
4. Novadaqs SPY Imaging System named Product of the Year by Frost and Sullivan
5. Novadaq to present at BMO Healthcare Conference
6. Novadaq to present at Piper Jaffray Healthcare Conference
7. Novadaq announces third quarter 2007 conference call and webcast
8. Novadaq launches PINPOINT: Companys first minimally invasive imaging system
9. Novadaq Resumes Normal Business Operations by Securing ICG for SPY
10. Alexion to Present at Investor Conferences
11. BioMarin to Present at the Cowen and Company 28th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...to condemn hurtful comments, study suggests , ... people overestimate how strongly they would react...Sixty-three percent of study participants at York ... an experiment with a white person rather than a b...comments about the black person when he left the r...
(Date:1/8/2009)... Jan. 8 Hanger Orthoped...ce that throughout the fourth quarter of 2008 it a...r, Rocky Mountain Orthotic-Prosthetics Center, Rie...irst Coast Orthotics & Prosthetics, and Orthop...ons add patient care centers to existing markets i...
(Date:1/8/2009)...Md., Jan. 8 /PRNewswire-Asia/ -- Chindex Internati...any"), a leading independent American,provider of...eople,s Republic,of China, today announced that t... Conference, to be held in Shanghai on January 12t...nference will be held at the Pudong Shangri-,La h...
(Date:1/8/2009)...an. 8 Cephalon, Inc . (...o, Jr., Ph.D., Chairman and CEO will present at t...n January 13, 2009 in San Francisco, CA at approxi...). The presentation will be webcast live on the in... , , The webcast will be archived for one week...
Breaking Medicine News(10 mins):Health News:Many Turn Blind Eye to Racism 2Health News:Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue 2Health News:Chindex International Inc. Announces Participation in the 2009 UBS Greater China Conference 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 3
...herapy -- a chemical treatment to remove lead from... behavioral problems that result from lead exposur..., in a further finding that has implications for t...e researchers say that when rats with no lead in t...
...ducted on women in their 70's to observe the relat...n older women. This study followed nearly 12,000 ...ding reports that moderate alcohol intake (1-2 dri...content) may lead to increased quality of life and...
...an’s heart is through his stomach, they say! Is th...chen? Food for thought, of course! Meanwhile, what...equently good health? Grab the attention of the la...esearchers from Newcastle University’s Human Nutri...
...d of the Delhi government will investigate the cas...ated //upon for congenital hernia instead of an ex...ijpal was taken to a wrong operation theatre Tuesd..., where he had been admitted for removing the sixt...
Other Medicine News:Health News:Pros and Cons of Therapy for Lead Exposure 2Health News:How a Woman Holds Fort in Her Little Kingdom – The Kitche 2
(Date:1/8/2009)...e in an ongoing Phase Ib trial demonstrated a 2.5 ..., , Conference Call Today at 8:30AM EST , , ... Pharmaceuticals, Inc. (Nasdaq: ANDS ) today ann... Phase Ib clinical trial of ANA598, the Company,s ...r. ANA598 was very well-tolerated and demonstrate...
(Date:1/7/2009)...ease , , WHITE PLAINS, N.Y., Jan. 7 /PRNewswire...that the decades-long rise in the United States pr...han ever at increased risk of death and disability...3,000 babies were born too soon in 2006, according...ch today released "Births: Final data for 2006," N...
(Date:1/7/2009)...ntan Puhua Hospital Stem Cells Center ( http://www...ng stem cells to effectively treat neurological di...ced additions to its medical and research staff th...apabilities for growing numbers of incoming intern...he distinguished Dr. Jiang Ping, who was named Chi...
(Date:1/6/2009)...ntaining a healthy immune system , , PURCHASE, ...study in Nutrition and Cancer (60(5), 643-651) b...a, Japan has shown that AHCC (Active Hexose Correl...ing the number of dendritic cells (DCs). DCs are a...senting foreign substances to other immune system ...
Breaking Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6Preterm Births Rise 36 Percent Since Early 1980s 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 2Stem Cell Treatment Leader Tiantan Puhua Adds Experienced International Medical Staff for Expanding Numbers of Patients 3Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 3Delayed angioplasty big bucks no bang 5485 1Delayed angioplasty big bucks no bang 5485 2Genelabs Technologies to Present at the Acumen Biofin Rodman 26 Renshaw 9th Annual Healthcare Conference 5482 1Allos Therapeutics Reports Third Quarter 2007 Financial Results 5479 1Allos Therapeutics Reports Third Quarter 2007 Financial Results 5479 2Allos Therapeutics Reports Third Quarter 2007 Financial Results 5479 3Allos Therapeutics Reports Third Quarter 2007 Financial Results 5479 4Allos Therapeutics Reports Third Quarter 2007 Financial Results 5479 5Allos Therapeutics Reports Third Quarter 2007 Financial Results 5479 6Allos Therapeutics Reports Third Quarter 2007 Financial Results 5479 7Oncology Physician Resource 28OPR 29 Extends Agreement With OTN and Onmark as Oncology Services Partner 5476 1Oncology Physician Resource 28OPR 29 Extends Agreement With OTN and Onmark as Oncology Services Partner 5476 2Oncology Physician Resource 28OPR 29 Extends Agreement With OTN and Onmark as Oncology Services Partner 5476 3
...7 /PRNewswire-FirstCall/ -- Vanda,Pharmaceuticals ...f,the Henry Ford Sleep Disorders and Research Cent...on on recent Phase III clinical,trial results for ...ptor agonist, at SLEEP 2007, the 21st annual meeti... (APSS). , The Vanda presentation will take place ...
...IRE)--Jun 8, 2007 - Archemix Corp., a,biotechnolog...tamers, announced the successful completion of a P...1779. ARC1779 is designed to,selectively block the... by inhibiting the binding of von Willebrand Facto...ed vWF is scientifically,recognized as the first s...
Other Medicine Technology:Vanda Pharmaceuticals To Present Data on VEC-162 at SLEEP 2007, the,Annual Meeting of the Associated Professional Sleep Societies 2Archemix Announces Completion of Phase 1 Trial of ARC1779 2Archemix Announces Completion of Phase 1 Trial of ARC1779 3
...tome Semi-Automatic Tissue Sectioning System has m...ctioning system. Researchers from around the globe...ir fresh and fresh fixed tissue sectioning needs f...issue Sectioning Systems, the biological viability...
...3000 Deluxe Sectioning System provides a versatile...ant tissues. The 3000 employs a vibrating blade p...or embedding. The creation of artifacts, the alte...tivities, and other deleterious effect inherent in...
The Vibratome comes standard with a square vice mounting device. These specimen blocks are utilized for mounting specimens and placing in the Vibratome holding vice. The blocks are annodized black
These specialty razor blades are feather thin and very sharp. Most users have found an increased quality level in Vibratome sections with these blades.
Medicine Products: